Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 240

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 240
---
 Agreement dated January 21, 2025 between the Company and GIVF (“Purchase Agreement”), the Company purchased
all of the Assets (as defined in the Purchase Agreement) and IP Licenses (as defined in the Purchase Agreement) relating to the MicroSort
technology from GIVF for a cash consideration of $750,000 and a share consideration of 125,000 Ordinary Shares (“MicroSort Acquisition”).
Under the terms of the agreement, the Company acquired the technology for US$5 million, which was satisfied through a combination of
US$750,000 in cash and the issuance of 2,500,000 ordinary shares (as was adjusted to 12,500 ordinary shares after the Reverse Stock Split
on February 11, 2025 and the Reverse Stock Split on May 5, 2025) at a deemed value of US$1.70 per share.

On February 18, 2025, the
Company entered into a cooperation agreement with FERTILITY GROUP LLC (“BOBCARE”) to jointly develop fertility services in
the Kyrgyzstan market. The collaboration aims to combine NewGen’s technical expertise in fertility treatments with BOBCARE’s
market resources in the region. This strategic partnership is anticipated to contribute to NewGen’s market presence over the next
three years, improving the competitive position of both parties in the Kyrgyzstan market. Both companies will work together on several
initiatives, including enhancing clinical protocols and patient management systems, knowledge exchange between fertility specialists,
coordinated marketing and brand-building activities in Kyrgyzstan, and developing specialized fertility treatment options for the regional
market.

On March 31, 2025, the Company
terminated the binding term sheet with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) regarding
their previously announced reverse merger transaction. On the grounds of non fulfilment of certain criteria as contained in the term
sheet.

On March 31, 2025, the Company’s
Board approved certain amendments to its Share Incentive Plan of 2024, the awards of which are valid for a period of 10 years from March
28, 2025, whereby the maximum aggregate number of shares with respect to which Awards may be granted under the Plan shall be 105,426
Shares, which may be increased from time to time as determined by the Board or Committee of the Board, in an amount equal to 20% of the
then outstanding ordinary shares of the Company at the time of such increase.